A carregar...
Therapeutic Targeting of RAS: New Hope for Drugging the “Undruggable”
RAS is the most frequently mutated oncogene in cancer and a critical driver of oncogenesis. Therapeutic targeting of RAS has been a goal of cancer research for more than 30 years due to its essential role in tumor formation and maintenance. Yet the quest to inhibit this challenging foe has been elus...
Na minha lista:
| Publicado no: | Biochim Biophys Acta Mol Cell Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6937383/ https://ncbi.nlm.nih.gov/pubmed/31678118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbamcr.2019.118570 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|